Effect of Acute Sleep Restriction on Responses to Hypoxia
HypSom
2 other identifiers
observational
25
1 country
1
Brief Summary
At altitude, humans are exposed to environmental hypoxia induced by the decrease in barometric pressure. On duty or in training, mountain troops, paratroopers or aircrew are regularly exposed to altitude. The effects of altitude on humans occur gradually from 1500 m and depend on both the duration of exposure and the altitude level. Cognitive disorders can occur from 3500 m (threshold of disorders) but there is a very large inter-individual variability. The countermeasure to altitude hypoxia is oxygen but its use is not systematic between 3000 and 4000 m. Its use depends on the duration of exposure, without clearly established standards. Incapacitating effects on the operational capacity and health of soldiers can therefore occur as early as 3500 m. In operations or during training, altitude exposure is often associated with a significant sleep debt (particularly during night or early morning missions), jet lag or precarious rest conditions in overseas operations. These sleep restrictions promote the degradation of mental performance with effects similar to those observed in hypoxia. The combination of these constraints induces a physiological stress which can favour alterations in mental performance, an increase in incapacity, intolerance to altitude or the occurrence of altitude-related pathologies in military personnel. This could occur in particular in the operational zone around the threshold of disorders (3500 m) where the indication of oxygen is discussed. The objective of this study is to assess the impact of acute sleep restriction on hypoxia tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedStudy Start
First participant enrolled
October 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedNovember 7, 2022
November 1, 2022
1.6 years
September 16, 2022
November 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Mean reaction time (in ms) to the 10-minute psychomotor vigilance task (PVT-10), at the end of the exposure.
PVT-10 is a sustained-attention, reaction-timed task that measures the consistency with which subjects respond to a visual stimulus. The participant sits in front of a computer. He has a screen in front of him with a 4-digit counter (0 at the start). He is instructed to click the left mouse button as fast as possible when the counter starts to scroll. The counter returns to zero when the participant has clicked. Reaction time (in ms) is calculated for each stimulus.
Through study completion (20.5 months)
Interventions
Each participant will be exposed to the hypoxic environment on 2 occasions (one after a normal sleep night and one after sleep deprivation). Each exposure will be for 5 hours at a FiO2 of 13.2% (3500 m simulated altitude). This exposure will be carried out in a normobaric hypoxic tent (Sporting Edge®).
Each participant will be exposed to sleep deprivation on 2 occasions (one before normoxia exposure and one before hypoxia exposure). Each sleep deprivation involves a time spent in bed of 3 hours (03h00 - 06h00). Sleep deprivation will be carried out in a sleep apartment. Sleep duration and quality will be assessed using a sleep headband (Dreem®), actigraphs Actiwatch® and E4 Empatica®) and a sleep diary.
Participants will perform several cognitive tasks in the following conditions: * in normoxia (FiO2 = 21%) after a night of usual sleep (\> 6 hours) ; * in normoxia (FiO2 = 21%) after a night of reduced sleep (3 hours); * in normobaric hypoxia (FiO2 = 13.2%) after a night of normal sleep (\> 6 hours); * in normobaric hypoxia (FiO2 = 13.2%) after a night of reduced sleep (3 hours).
Eligibility Criteria
The study population will be composed of healthy active young men.
You may qualify if:
- Male
- Healthy
- Between 18 and 45
- Smoking \< 5 cigarettes per day or nicotine-free electronic cigarette
- Having regular physical activity (between 1 and 4 hours of physical activity per week)
- Affiliated or entitled to a social security plan
- No contraindication to physical exercise
- Having given their consent
You may not qualify if:
- Female
- BMI \> 30
- Active medical pathology (cardiological, renal, hepatic, cutaneous, neurological, etc.),
- History of active pathology of less than 6 months
- Significant deviation with the normal values observed during the interrogation, clinical examination or electrocardiogram
- Having spent time at altitude (\> 3500 m) during the last 3 months
- Absolute or relative contraindication to a stay at high altitude
- Medical contraindication to sport practice
- Skin allergy to modified ethanol or capsaicin
- Wearing a pacemaker or ferromagnetic implants
- Poor venous capital
- Pittsburgh Sleep Quality Index Questionnaire \> 5
- Usual sleep duration \< 6 hours
- Not covered by a health insurance plan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Recherche Biomédicale des Armées
Brétigny-sur-Orge, 91223, France
Related Publications (1)
Pontiggia A, Quiquempoix M, Fabries P, Beauchamps V, Jacques C, Guillard M, Van Beers P, Malle C, Gomez-Merino D, Koulmann N, Chennaoui M, Sauvet F; HYPSOM Investigator Group. Robust multimodal mental workload classification: A cross-physiological condition machine learning approach. Comput Methods Programs Biomed. 2026 Jan 14;277:109251. doi: 10.1016/j.cmpb.2026.109251. Online ahead of print.
PMID: 41576780DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2022
First Posted
October 3, 2022
Study Start
October 26, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
November 7, 2022
Record last verified: 2022-11